VivoSim Labs, Inc. Non Peo Neo Avg Total Comp Amt
VivoSim Labs, Inc. (VIVS) reported Non Peo Neo Avg Total Comp Amt of $217.59 thousand for the 12-month period ending 2026-03-31, per its DEF 14A filed 2026-08-21.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-08-21
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2026-03-31 | $217.59K DEF 14A · filed 2026-08-21 |
| 2025-03-31 | $135.90K DEF 14A · filed 2026-08-21 |
| 2024-03-31 | $343.08K DEF 14A · filed 2026-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |